FTD is characterized by the deposition of abnormal DNA-binding protein 43 (TDP-43) or tau protein aggregates in the frontal and temporal lobes of the brain, resulting in neuronal degeneration, behavioral abnormalities, or language dysfunction with progressive degeneration of the frontal and temporal lobes. The gene discussed is TARDBP; the disease is frontotemporal dementia.